Free Trial
NASDAQ:OPRX

OptimizeRx (OPRX) Stock Price, News & Analysis

OptimizeRx logo
$16.58 +0.44 (+2.71%)
As of 10:52 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About OptimizeRx Stock (NASDAQ:OPRX)

Key Stats

Today's Range
$15.97
$16.64
50-Day Range
$12.48
$17.59
52-Week Range
$3.78
$18.22
Volume
55,149 shs
Average Volume
379,723 shs
Market Capitalization
$307.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.81
Consensus Rating
Moderate Buy

Company Overview

OptimizeRx Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
25th Percentile Overall Score

OPRX MarketRank™: 

OptimizeRx scored higher than 25% of companies evaluated by MarketBeat, and ranked 573rd out of 664 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    OptimizeRx has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on 8 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    OptimizeRx has only been the subject of 3 research reports in the past 90 days.

  • Read more about OptimizeRx's stock forecast and price target.
  • Earnings Growth

    Earnings for OptimizeRx are expected to grow in the coming year, from ($0.33) to ($0.29) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of OptimizeRx is -29.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of OptimizeRx is -29.89, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    OptimizeRx has a PEG Ratio of 2.40. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    OptimizeRx has a P/B Ratio of 2.51. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    6.81% of the float of OptimizeRx has been sold short.
  • Short Interest Ratio / Days to Cover

    OptimizeRx has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in OptimizeRx has recently decreased by 0.87%, indicating that investor sentiment is improving.
  • Dividend Yield

    OptimizeRx does not currently pay a dividend.

  • Dividend Growth

    OptimizeRx does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.81% of the float of OptimizeRx has been sold short.
  • Short Interest Ratio / Days to Cover

    OptimizeRx has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in OptimizeRx has recently decreased by 0.87%, indicating that investor sentiment is improving.
  • News Sentiment

    OptimizeRx has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Computer and Technology companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for OptimizeRx this week, compared to 3 articles on an average week.
  • Search Interest

    14 people have searched for OPRX on MarketBeat in the last 30 days. This is an increase of 56% compared to the previous 30 days.
  • MarketBeat Follows

    13 people have added OptimizeRx to their MarketBeat watchlist in the last 30 days. This is an increase of 1,200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, OptimizeRx insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 5.60% of the stock of OptimizeRx is held by insiders.

  • Percentage Held by Institutions

    76.47% of the stock of OptimizeRx is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about OptimizeRx's insider trading history.
Receive OPRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OptimizeRx and its competitors with MarketBeat's FREE daily newsletter.

OPRX Stock News Headlines

OptimizeRx announces leadership team advancements
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.tc pixel
Brokerages Set OptimizeRx Corp. (NASDAQ:OPRX) Target Price at $11.81
OptimizeRx (NASDAQ:OPRX) Price Target Raised to $20.00
See More Headlines

OPRX Stock Analysis - Frequently Asked Questions

OptimizeRx's stock was trading at $4.86 at the beginning of 2025. Since then, OPRX shares have increased by 232.1% and is now trading at $16.14.

OptimizeRx Corp. (NASDAQ:OPRX) posted its earnings results on Monday, May, 12th. The company reported $0.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.11) by $0.19. The company earned $21.93 million during the quarter, compared to the consensus estimate of $18.69 million. OptimizeRx had a negative net margin of 9.42% and a positive trailing twelve-month return on equity of 4.50%.
Read the conference call transcript
.

OptimizeRx's top institutional investors include Blair William & Co. IL (3.40%), Kennedy Capital Management LLC (2.54%), Manatuck Hill Partners LLC (2.45%) and Geode Capital Management LLC (2.16%). Insiders that own company stock include William J Febbo, James Paul Lang and Marion Odence-Ford.
View institutional ownership trends
.

Shares of OPRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that OptimizeRx investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Tesla (TSLA), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Intel (INTC).

Company Calendar

Last Earnings
5/12/2025
Today
8/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
COMP - SOFTWARE
Sub-Industry
Business Services
Current Symbol
NASDAQ:OPRX
CIK
1448431
Employees
100
Year Founded
N/A

Price Target and Rating

High Price Target
$20.00
Low Price Target
$5.00
Potential Upside/Downside
-26.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.73
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.54)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
2.4
Net Income
-$18.66 million
Net Margins
-9.42%
Pretax Margin
-8.88%
Return on Equity
4.50%
Return on Assets
3.12%

Debt

Debt-to-Equity Ratio
0.21
Current Ratio
2.57
Quick Ratio
2.57

Sales & Book Value

Annual Sales
$92.13 million
Price / Sales
3.25
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.43 per share
Price / Book
2.51

Miscellaneous

Outstanding Shares
18,570,000
Free Float
17,525,000
Market Cap
$299.72 million
Optionable
Optionable
Beta
1.33

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:OPRX) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners